These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 12959218

  • 1. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Press R, Pashenkov M, Jin JP, Link H.
    J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Zhang HL, Zhang XM, Mao XJ, Deng H, Li HF, Press R, Fredrikson S, Zhu J.
    Acta Neurol Scand; 2012 Feb; 125(2):129-35. PubMed ID: 21434877
    [Abstract] [Full Text] [Related]

  • 4. Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy.
    Mahad DJ, Howell SJ, Woodroofe MN.
    J Neurol Neurosurg Psychiatry; 2002 Sep; 73(3):320-3. PubMed ID: 12185171
    [Abstract] [Full Text] [Related]

  • 5. The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain-Barré syndrome from chronic inflammatory demyelinating polyneuropathy.
    Sainaghi PP, Collimedaglia L, Alciato F, Leone MA, Naldi P, Molinari R, Monaco F, Avanzi GC.
    Cytokine; 2010 Aug; 51(2):138-43. PubMed ID: 20538476
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
    Csurhes PA, Sullivan AA, Green K, Pender MP, McCombe PA.
    J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
    [Abstract] [Full Text] [Related]

  • 9. [Immunopathology and treatments of Guillain-Barré syndrome and of chronic inflammatory demyelinating polyneuropathy].
    Radziwill AJ, Kuntzer T, Steck AJ.
    Rev Neurol (Paris); 2002 Mar; 158(3):301-10. PubMed ID: 11976589
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barré syndrome and experimental autoimmune neuritis.
    Orlikowski D, Chazaud B, Plonquet A, Poron F, Sharshar T, Maison P, Raphaël JC, Gherardi RK, Créange A.
    J Neuroimmunol; 2003 Jan; 134(1-2):118-27. PubMed ID: 12507779
    [Abstract] [Full Text] [Related]

  • 16. IL-8 as a potential biomarker in Guillain-Barre Syndrome.
    Breville G, Lascano AM, Roux-Lombard P, Lalive PH.
    Eur Cytokine Netw; 2019 Dec 01; 30(4):130-134. PubMed ID: 32096474
    [Abstract] [Full Text] [Related]

  • 17. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M, Suzuki S, Takada K, Kusunoki S.
    J Neuroimmunol; 2011 Oct 28; 239(1-2):87-90. PubMed ID: 21914557
    [Abstract] [Full Text] [Related]

  • 18. Sequential expression of chemokines in experimental autoimmune neuritis.
    Kieseier BC, Krivacic K, Jung S, Pischel H, Toyka KV, Ransohoff RM, Hartung HP.
    J Neuroimmunol; 2000 Oct 02; 110(1-2):121-9. PubMed ID: 11024541
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy.
    Inglis HR, Csurhes PA, McCombe PA.
    J Neurol Neurosurg Psychiatry; 2007 Apr 02; 78(4):419-22. PubMed ID: 17158557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.